- Home
- DNTH vs NPK Comparison
DNTH vs NPK Comparison
Compare DNTH & NPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- NPK
- Stock Information
- Founded
- DNTH 2015
- NPK 1905
- Country
- DNTH United States
- NPK United States
- Employees
- DNTH N/A
- NPK N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- NPK Ordnance And Accessories
- Sector
- DNTH Health Care
- NPK Industrials
- Exchange
- DNTH Nasdaq
- NPK Nasdaq
- Market Cap
- DNTH 711.2M
- NPK 698.8M
- IPO Year
- DNTH N/A
- NPK N/A
- Fundamental
- Price
- DNTH $21.66
- NPK $99.30
- Analyst Decision
- DNTH Strong Buy
- NPK
- Analyst Count
- DNTH 9
- NPK 0
- Target Price
- DNTH $46.43
- NPK N/A
- AVG Volume (30 Days)
- DNTH 285.9K
- NPK 45.1K
- Earning Date
- DNTH 11-07-2024
- NPK 02-18-2025
- Dividend Yield
- DNTH N/A
- NPK 1.01%
- EPS Growth
- DNTH N/A
- NPK 43.29
- EPS
- DNTH N/A
- NPK 4.76
- Revenue
- DNTH $5,366,000.00
- NPK $351,952,000.00
- Revenue This Year
- DNTH $100.14
- NPK N/A
- Revenue Next Year
- DNTH N/A
- NPK N/A
- P/E Ratio
- DNTH N/A
- NPK $20.49
- Revenue Growth
- DNTH 51.41
- NPK N/A
- 52 Week Low
- DNTH $14.82
- NPK $69.58
- 52 Week High
- DNTH $33.77
- NPK $99.33
- Technical
- Relative Strength Index (RSI)
- DNTH 45.12
- NPK 71.40
- Support Level
- DNTH $18.72
- NPK $96.15
- Resistance Level
- DNTH $28.65
- NPK $98.38
- Average True Range (ATR)
- DNTH 2.31
- NPK 1.64
- MACD
- DNTH -0.33
- NPK -0.37
- Stochastic Oscillator
- DNTH 32.14
- NPK 98.18
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About NPK National Presto Industries Inc.
National Presto Industries Inc has an eclectic product portfolio consisting of household appliances, ammunition, and diapers. The company operates in three segments viz Defense, Housewares/Small Appliance, and Safety. The defense segment which is engaged in manufacturing 40mm ammunition, precision mechanical and electro-mechanical assemblies, and medium caliber cartridge cases; performs Load, Assemble, and Pack (LAP) operations on ordnance-related products for the U.S. Government and prime contractor. While Housewares/Small Appliance segment designs, markets, and distributes housewares and small electrical appliances; the safety segment provides safety technology empowering organizations and individuals to protect what is more important.